From Wikipedia the free encyclopedia
|Chemical and physical data|
|Molar mass||543.72 g·mol−1|
|3D model (JSmol)|
Radalbuvir (INN, also known as GS-9669) is an experimental antiviral drug for the treatment of hepatitis C virus (HCV) infection developed by Gilead Sciences. Radalbuvir acts as an NS5B inhibitor. It is currently in clinical trials.
- "International Nonproprietary Names for Pharmaceutical Substances" (PDF). WHO Drug Information. 28 (4). 2014.
- "Search of: GS-9669 — List Results". ClinicalTrials.gov.
|This antiinfective drug article is a stub. You can help Wikipedia by expanding it.|